Applied DNA Sciences, Inc. (NASDAQ:APDN) (the “Company”), a leader in polymerase chain reaction (“PCR”)-based technologies, announced that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (“ADCL”), has initiated analytical validation of a Company-developed, PCR-based monkeypox virus test that is specific for the genetic signature of the monkeypox virus. The test has been developed as a type of NYSDOH Laboratory Developed Test (“LDT”). If the test is validated by ADCL, a validation package will be submitted to New York State Department of Health (“NYSDOH”) for approval. If approved, the test will be used to power ADCL’s monkeypox testing services.
Paul Krugman Thinks ‘Soft Landing Is Looking Increasingly Plausible’ After Inflation Cools Down
Nobel laureate and noted economist Paul Krugman has expressed optimism over the latest inflation report, saying that a soft landing looks increasingly plausible.
